Synapses are the basic units of information transmission, processing and integration in the nervous system. Dysfunction of the synaptic development has been recognized as one of the main reasons for mental dementia and psychiatric diseases such as Alzheimer's disease and autism. However, the underlying mechanisms of the synapse formation are far from clear. Here we report that phospholipase D1 (PLD1) promotes the development of dendritic spines in hippocampal neurons. We found that overexpressing PLD1 increases both the density and the area of dendritic spines. On the contrary, loss of function of PLD1, including overexpression of the catalytically-inactive PLD1 (PLD1ci) or knocking down PLD1 by siRNAs, leads to reduction in the spine density and the spine area. Moreover, we found that PLD1 promotes the dendritic spine development via regulating the membrane level of N-cadherin. Further studies showed that the regulation of surface N-cadherin by PLD1 is related with the cleavage of N-cadherin by a member of the disintegrin and metalloprotease family-ADAM10. Taking together, our results indicate a positive role of PLD1 in synaptogenesis by inhibiting the ADAM10 mediated N-cadherin cleavage and provide new therapeutic clues for some neurological diseases.
PLD1 exhibit deficiency in brain development and cognitive function 29 highly suggests that PLD1 may regulate the development of dendritic spines. The growth and maturation of dendritic spines require the neurons to provide enough lipids for the rapid and significant increase in membrane and to clear the obstacles such as extracellular matrix for the dendritic spines to grow. In hippocampus, PLD1 has been reported to be expressed mainly in neurons and regulate the outgrowth of mossy fibers by stimulating the secretion of tissue plasminogen activator (tPA) which is dependent on its catalytic products PA 30, 31 . Combined with the fact that PLD1-mediated tPA signaling pathway participates hippocampal mossy fiber sprouting 31 , we believe that PLD1 may also play an important part in neuronal dendritic spine development.
To verify our hypothesis, we investigated the role of PLD1 on cultured hippocampal neurons. We discovered that overexpression of PLD1 increases the density and the area of dendritic spines, while overexpressing catalytically-inactive PLD1 (PLD1ci) functions oppositely. Consistently, knocking down PLD1 also restricts the development of dendritic spines. Further study showed that N-cadherin acts downstream of PLD1 in dendritic spine development. Finally we found that PLD1 promotes the dendritic spine development by preventing N-cadherin from being cleaved by ADAM10, suggesting a potential role of PLD1 as an important regulator and a novel therapeutic target in neurological diseases.
Results
PLD1 promotes the development of dendritic spines. First, we used the in vitro cultured hippocampal neurons to explore the function of PLD1 in dendritic spine development. The neurons were transfected with HA-tagged empty vector (Vector), PLD1 and PLD1ci along with GFP to show the morphology of neurons at DIV (days in vitro) 8 and analyzed at DIV 15, which is the time window for dendritic spine development 32, 33 . The results showed that compared to the empty vector control, overexpressing PLD1 in hippocampal neurons induced the growth and maturation of dendritic spines as measured by their density and area ( Fig. 1A ). However, when overexpressed with PLD1ci, both the density and the area of dendritic spines were significantly decreased ( Fig. 1A) . These data imply a positive role of PLD1 in dendritic spine development. In order to testify the function of endogenous PLD1, we employed RNAi (RNA interference) approaches on cultured neurons. Lentivirus expressing short hairpin RNA and small interfering RNA targeting the same sequence of PLD1 (PLD1 shRNA and PLD1 siRNA) were constructed and applied respectively on cortical neurons and hippocampal neurons. Western blots from cultured cortical neurons infected with the lentivirus of control shRNA or PLD1 shRNA showed that the PLD1 shRNA could effectively reduce the protein level of endogenous PLD1 in neurons ( Fig. 1B) , which confirms the efficiency of the selected sequence. Then we transfected the cultured hippocampal neurons with GFP plus control siRNA or PLD1 siRNA. We found that knocking down PLD1 in cultured hippocampal neurons dramatically decreased the spine density and spine area (Fig. 1C ). These data indicate that PLD1 promotes the development of dendritic spines.
PLD1 regulates the membrane level of N-cadherin.
In order to form a functional synapse, the dendritic spines must match precisely with the presynaptic terminals 34 . The generation of this connectivity pattern requires the homophilic interaction of cell adhesion molecules (CAMs) located at both the axonal terminal and the dendritic spines 34 . N-cadherin, one of the important CAMs in the nervous system, has been reported to locate at the newly formed dendritic spines to mediate the pre-and post-synaptic interaction 35, 36 . Since N-cadherin executes its function in synaptic development by locating at the cell membrane, we examined the potential effect of PLD1 on the membrane level of N-cadherin. We treated cortical neurons with 1-butanol, which inhibits the production of PA 37 , or 2-butanol as a control, and then did surface biotinylation assays. We found that compared to the control groups, application of 1-butanol reduced the level of membrane N-cadherin in a dose-dependent manner ( Fig. 2A,B ). Because the effects of 1-butanol have been reported to be unspecific 38 , we examined the effect of another specific small-molecule PLD1 inhibitor, VU 0155069 39, 40 , on the membrane localization of N-cadherin. The results showed that treatment with VU 0155069 led to decreased membrane level of N-cadherin in a dose-dependent manner as well ( Fig. 2C ,D). To further specifically address the role of PLD1 on membrane N-cadherin, we infected cortical neurons with lentivirus expressing either control shRNA or PLD1 shRNA, and found that knocking down PLD1 in cortical neurons also reduced the membrane level of N-cadherin ( Fig. 2E ). These results demonstrate that PLD1 may promote the dendritic spine development through regulating the membrane level of N-cadherin. PLD1 regulates the dendritic spine development via N-cadherin. The results above suggest that there might be a functional link between PLD1 and N-cadherin in the dendritic spine development. So we conducted a series of knocking down and rescuing experiments on hippocampal neurons. Co-expressing N-cadherin could effectively restore the reduced spine density and spine area caused by PLD1 siRNA (Fig. 3A) . Consistently, knocking down N-cadherin by shRNA (shN-cad) led to inhibition of the dendritic spine development compared to the control group (shGFP) ( Fig. 3B ). However, co-overexpressing PLD1 failed to rescue the effects of knocking down N-cadherin ( Fig. 3B ). These data show that N-cadherin acts downstream of PLD1 in promoting the development of dendritic spines. PLD1 prevents the cytoplasmic cleavage of N-cadherin. The stabilization of N-cadherin on cell membrane is dependent on its cytoplasmic interaction with β-catenin, which can be anchored to the cell cytoskeleton through α-catenin 41, 42 . It has also been reported that N-cadherin without its cytoplasmic domain acts as a dominant negative mutant to interfere the proper development of the neuronal dendrites and dendritic spines [43] [44] [45] , highlighting the necessity for the cytoplasmic domain of N-cadherin in dendritic spine development. In addition, N-cadherin can be cleaved by ADAM10, a member of the disintegrin and metalloprotease family, thus intracellularly generating a C-terminal fragment named CTF1 at dendritic spines [46] [47] [48] . Since PLD1 is a cytoplasmic protein, there is a possibility that PLD1 may regulate the membrane level of N-cadherin through affecting its cytoplasmic domain. Western blots showed that treatment of PLD inhibitor 1-butanol in the cultured cortical neurons led to an increase in the level of CTF1, and the higher concentration of 1-butanol used, the more CTF1 produced ( Fig. 4A,B ). The use of specific PLD1 inhibitor VU 0155069 brought about similar change in the level of CTF1 ( Fig. 4C,D) . Moreover, knocking down PLD1 in the cultured cortical neurons also facilitated the production of CTF1 (Fig. 4E ), confirming the specific protective role of PLD1 in N-cadherin proteolysis. We further examined whether the protection of PLD1 for complete N-cadherin involves in ADAM10. The cortical neurons were infected with lentivirus expressing PLD1 shRNA or control shRNA and simultaneously treated with different concentration of GI254023X which is a specific inhibitor of ADAM10 49, 50 or vehicle control. We found that ADAM10 inhibitor reversed the effects of knocking down PLD1 on the level of CTF1 ( Fig. 5A ), validating that PLD1 disrupts ADAM10-mediated cleavage of N-cadherin. Further study showed that ADAM10 forms a complex with PLD1 in N2a cells transfected with HA-tagged PLD1 compared to the HA-tagged vector control by co-immunoprecipitation ( Fig. 5B ). Altogether, our results demonstrate that PLD1 prevents ADAM10 from cleaving N-cadherin dependent on the catalytic activity of PLD1 and PLD1 may associate with ADAM10 to fulfill such function.
Discussion
PLD1 has been reported to function in various neuronal events, including neurite outgrowth and neurotransmitter release 31, 51, 52 . Our work first time identifies a positive role of PLD1 in the dendritic spine development, enriching the list for the roles of PLD1 play in the nervous system. We further reveal a new downstream signaling pathway for PLD1: PLD1 protects N-cadherin from being cleaved via its enzymatic activity and associating with ADAM10, thus maintaining the stability of N-cadherin on cell membrane and promoting dendritic spine development ( Fig. 6) .
As a member of the phospholipase D lipid-signaling enzyme superfamily, the enzymatic activity of PLD1 is important for its function. PLD1 catalyzes the hydrolysis of PC which is the most abundant membrane phospholipid, and is well-documented for its role in membrane-trafficking events 53 , implying a potential role of PLD1 in dendritic spine morphogenesis. Our previous discovery showed that PLD1 is expressed at the later stage of neural development 28 , whereas its function in later stage remains unresolved. Here we found that PLD1 promotes the dendritic spine development by regulating the membrane level of N-cadherin in neurons. Our study showed that overexpression of PLD1ci led to apparent reduction in the spine density and spine area compared to both the empty control and wild-type PLD1 (Fig. 1A) . Additionally, inhibition of PLD activity by both 1-butanol and VU 0155069 dramatically depressed the membrane level of N-cadherin ( Fig. 2A-D) and promoted the production of CTF1 (Fig. 4A-D) . These results prove that the role of PLD1 in the dendritic spine development is also dependent on its enzymatic activity. One product of the PLD1-mediated hydrolysis is the second messenger PA, which has already been reported to promote the stability of dendritic spines 54 . Therefore, the effect of PLD1 on ADAM10 relies on the catalytic activity of PLD1. To form a functional synapse, the axonal terminal must be connected with dendritic spines correctly, which requires the interactions between the CAMs distributed at both the pre-and the post-synaptic components 55 . As a classical CAM, N-cadherin contains five extracellular domains which mediate the homophilic interaction between cells and a cytoplasmic domain interacting with β-catenin to link with the cytoskeleton system or to mediate the signal transduction from synapse to nucleus 56, 57 . Moreover, the extracellular domain of N-cadherin has been shown to associate with GluR2 subunit 58 , which provides important insights of how the postsynaptic receptors are aligned to bind with the neurotransmitters released from presynaptic active zone. In order to achieve this, N-cadherin on the cell membrane must be anchored to the cytoskeleton system to ensure the stability of the synaptic system. N-cadherin without the cytoplasmic domain will lose its ability to stabilize the synapses. Consequently, the cleavage of N-cadherin by proteases such as ADAM10 must be precisely regulated to accommodate the growth and dynamics of the system. However, the regulation of the proteolysis of N-cadherin is still not clear.
In our study, we found that knocking down PLD1 decreased the membrane level of N-cadherin (Fig. 2C) , but increased the level of N-cadherin CTF1 (Fig. 4C ). We also found that PLD1 regulates the integrity of N-cadherin through affecting ADAM10-mediated cleavage of N-cadherin. Based on our co-immunoprecipitation result, we propose that PLD1 may associate with ADAM10 and increase the local concentration of PA and choline, and these products keep ADAM10 from cutting down N-cadherin through either direct inhibition or changes in the rigidity of the cell membrane around ADAM10. In this way, PLD1 may stabilize the localization of membrane N-cadherin. We also have noticed that PLD1 has been reported to inhibit the production of Aβ and promote the neurite growth 59, 60 . In our model, we do not exclude the possibility that PLD1 may regulate the membrane level of N-cadherin through affecting γ-secretase-mediated N-cadherin cleavage. Nevertheless, our data support the conclusion that ADAM10 is at least one of the targets regulated by PLD1 to modulate the membrane level of N-cadherin.
Lipid signaling has attracted much attention for their importance in diverse cell biological processes and diseases, and the lipid-modifying enzymes such as the phospholipase D superfamily also gains plenty of focus for the outlook in serving as suitable therapeutic targets [61] [62] [63] . PLD1 has been characterized for its role in cancer, pulmonary embolism and stroke 64 . Synapses have been acknowledged as the places where memories are stored and loss of synapses occurs before the onset of some neurodegenerative diseases 65 . Our work about the role of PLD1 in dendritic spine development indicates that PLD1 should also correlate with neurological disorders including neurodevelopmental diseases and neurodegenerative diseases. Combined with previous reports 59, 60 and our results, it seems that PLD1 participates in the regulation of the function of several proteases which are responsible for membrane molecules processing. Therefore, it is promising to classify PLD1 as a pivotal molecule to modulate the activity of the proteases and neuronal development as well as a novel target for treating neurological diseases.
Materials and Methods
Animals. Sprague-Dawley (SD) rats were housed in a temperature-(23 ± 2 °C) and humidity-(50 ± 5%) controlled environment. The animals were maintained on a 12-h light/dark cycle with food and water ad libitum. All animal studies were approved by the Animal Center of the Peking University Health Science Center, and the experiments were carried out in accordance with the relevant guidelines, including any relevant details.
DNA constructs and chemicals. HA-tagged wild-type PLD1 (PLD1) and catalytically-inactive PLD1 (PLD1ci) plasmids were generously provided by Dr. Michael A. Frohman (Stony Brook University, Stony Brook, NY). myc-tagged N-cadherin (N-cad) plasmid was kindly provided by Prof. Tanaka (Osaka University, Suita, Osaka, Japan). The pcDNA3.1 vector plasmids with corresponding tag were used as control respectively.
Lentivirus, siRNAs and shRNAs co-expressing GFP were purchased from Shanghai Genechem. The target mRNA sequence were as follows: for PLD1, 5′-CUGGAAGAUUACUUGACAA-3′, which we have verified the efficiency of >90% knockdown effect in our previous reports 28 ; and for N-cadherin, 5′-GACUGGAUUUCCUGAAGAU-3′ 66, 67 . The corresponding nonspecific sequences were used as control respectively. The vectors for shRNAs co-expressing GFP were U6-MCS-Ubi-EGFP.
1-butanol, 2-butanol, GI254023X and DMSO were purchased from Sigma Aldrich. VU 0155069 was purchased from Tocris. GI254023X and VU 0155069 were diluted in DMSO for use.
Cell culture and transfection. Hippocampal and cortical neurons were obtained from embryonic day 18 rat embryos of either sex and plated onto 35-mm dishes coated with poly-D-lysine (Sigma Aldrich) at an appropriate density. After 4 h in plating media (10% fetal bovine serum in DMEM), the cultures were transferred to neurobasal medium supplemented with 2% B27 and 0.5 mM GlutaMAX-I (Gibco Invitrogen). Half of the medium was replaced with fresh medium every 3 days. At DIV 3, cytosine arabinoside (Sigma Aldrich) was added to the maintenance medium at a final concentration of 10 μM to inhibit glial proliferation. For morphological experiments, hippocampal neurons were transfected at DIV 8 with indicated plasmids and siRNAs along with GFP-expressing plasmid (pEGFP-N1) or shRNAs co-expressing GFP to label entire neurons using Lipofectamine-2000 (Invitrogen) following the manufacturer's guidelines and harvested at DIV 15. In Fig. 1A , the ratio of GFP and indicated plasmids used for transfection was 1:3; in Fig. 1C , the ratio of GFP and indicated siRNAs was 1:2; in Fig. 3A , the ratio of GFP, indicated siRNAs and plasmids was 1:2:6; and in Fig. 3B , the ratio of indicated shRNAs and plasmids was 1:3. For biochemical experiments, cortical neurons were infected with lentivirus or treated with reagents at DIV 6 and collected at DIV 7 or 8.
Mouse N2a cells were maintained in DMEM supplemented with 10% fetal bovine serum. The cells were transfected with Lipofectamine-2000 (Invitrogen) according to the manufacturer's instructions.
Analysis of neuronal morphology. Dissociated hippocampal neurons grown at low density were used to determine the morphological characteristics of the neurons. Hippocampal neurons were fixed at DIV15 in 4% paraformaldehyde and 4% sucrose in PBS for 20 min at room temperature, mounted on slides, and imaged using an Olympus confocal laser scanning microscope (FV1000) with a 60X (NA 1.42) objective at 3X zoom. Spine stacks were acquired at 0.35-μm z-intervals to image the entire thickness of the dendrite. Measurement and analysis of the images were performed using Image Pro Plus (Media Cybernetics). Spine density was presented as average number per 10 μm of dendrites. For spine area, the experimental groups were normalized to the control groups.
